Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e631a34265b4af3ff678428e350ca792 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34 |
filingDate |
2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cf705985070b7a7aadd20c4946af20d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8193796bab7cea8c20bf5de37c65ec8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a56e51f186e985e74788a2b39a51be6 |
publicationDate |
2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2432482-A1 |
titleOfInvention |
Parmaceutical composition for the treatment of heart diseases. |
abstract |
The present invention is related to a pharmaceutical composition comprising cells committed to the generation of heart tissue and at least one pharmaceutically acceptable excipient produced according to internationally recognized standards for pharmaceutical product manufacture, a process for the manufacture of such a pharmaceutical composition and a kit for the administration of said pharmaceutical composition which comprises a container containing said pharmaceutical composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2843042-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644181-B2 |
priorityDate |
2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |